More about

Etanercept

News
August 20, 2024
2 min read
Save

Biosimilars, originators discontinued at similar rates for inefficacy, adverse events

Biosimilars, originators discontinued at similar rates for inefficacy, adverse events

Subcutaneous TNF inhibitors and their biosimilars are discontinued due to inefficacy and adverse events at similar rates in patients with rheumatic diseases, according to data from Spain published in The Journal of Rheumatology.

News
August 15, 2024
2 min read
Save

Enbrel, Stelara to be discounted nearly 70% through Medicare price negotiations

Enbrel, Stelara to be discounted nearly 70% through Medicare price negotiations

The list prices of Stelara and Enbrel for Medicare users will be discounted nearly 70% come 2026 as a result of the first round CMS price negotiations with drugmakers, the White House has announced.

News
August 15, 2024
4 min read
Save

Medicare announces price cuts for 10 drugs in first round of drug price negotiations

Medicare announces price cuts for 10 drugs in first round of drug price negotiations

The Centers for Medicare & Medicaid Services announced lower Medicare Part D prices for 10 drugs that will take effect in 2026, according to a press release.

News
June 06, 2024
2 min read
Save

Targeted psoriatic arthritis therapies demonstrate low risk for serious infection

Targeted psoriatic arthritis therapies demonstrate low risk for serious infection

Serious infections were uncommon among patients with psoriatic arthritis exposed to targeted therapies for the first time in “a large and exhaustive” French cohort, according to data published in RMD Open.

News
June 01, 2024
8 min watch
Save

VIDEO: Recent advancements in rheumatoid arthritis

VIDEO: Recent advancements in rheumatoid arthritis

In this video, Maria Danila, MD, discusses recent advancements in rheumatoid arthritis.

News
May 23, 2024
9 min listen
Save

Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of May 20, 2024

Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of May 20, 2024

In this edition, difficult-to-treat psoriatic arthritis 'not all about the therapies', Samsung biosimilar comparable to etanercept and more.

News
May 09, 2024
2 min read
Save

Samsung biosimilar comparable to etanercept for psoriatic arthritis outcomes at 1 year

Samsung biosimilar comparable to etanercept for psoriatic arthritis outcomes at 1 year

Patients with psoriatic arthritis demonstrated similar disease activity outcomes and drug persistence after long-term treatment with either etanercept or its biosimilar SB4, according to data published in Arthritis Care & Research.

News
December 15, 2023
8 min read
Save

‘Tough to say’: Complications, guarded optimism surround Medicare price negotiations

‘Tough to say’: Complications, guarded optimism surround Medicare price negotiations

Following HHS’ blockbuster announcement of the first 10 drugs that would be subject to Medicare price negotiations, patients and providers alike have been looking forward to meaningful reductions in their costly treatments.

News
August 29, 2023
3 min read
Save

Medicare price negotiation list includes rheumatology drugs ustekinumab, etanercept

Medicare price negotiation list includes rheumatology drugs ustekinumab, etanercept

The first 10 drugs eligible for price negotiation through Medicare includes etanercept and ustekinumab, biologic therapies commonly used to treat patients with rheumatic diseases, the Biden administration announced.

News
July 20, 2023
2 min read
Save

Patients with low RA activity more likely to stay in remission after switch to monotherapy

Patients with low RA activity more likely to stay in remission after switch to monotherapy

Patients with rheumatoid arthritis who demonstrate lower disease activity are more likely to remain in LDA or remission after switching from combination therapy to monotherapy, according to data published in the Journal of Rheumatology.

View more